Please assess the completion status of the following clinical trial:

Trial Title: Letrozole in Patients With Hepatopulmonary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Diagnosis of moderate to very severe hepatopulmonary syndrome which consists of having all 3 of the following conditions:~  * Presence of liver disease or portal hypertension~ * Intrapulmonary shunting on contrast-enhanced echocardiogram~ * Hypoxemia \[A-a gradient ≥15mmHg (or ≥20mmHg if age \>64) and PaO2\<80mmHg on arterial blood gas testing\]~* Child-Pugh class A or B liver disease~* MELD score \< 20~* ≥ 18 years old~* Female subjects must be post-menopausal (defined as 12 months of spontaneous amenorrhea or 6 weeks postsurgical bilateral oophorectomy without or without hysterectomy)~* Ability to provide informed consent~Exclusion Criteria~* Enrollment in a clinical trial or concurrent use of another investigational drug or device therapy (i.e., outside of study treatment) during, or within 28 days of baseline~* Current hepatic encephalopathy~* Expectation of liver transplant within six months of randomization~* Concomitant lung disease defined as restriction (TLC \< 70%) or obstruction (FEV1 \< 80% \& FEV1/FVC \< 70%)~* Inability to comply with the study protocol~* Osteoporosis~* Premenopausal women (those who have not reached 1 year absence of menarche)~* Vulnerable study population, including imprisoned individuals, or those who cannot consent on their own.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Letrozole Group (Type: EXPERIMENTAL): Subjects with hepatopulmonary syndrome will get the study drug letrozole
- Placebo Group (Type: PLACEBO_COMPARATOR): Subjects with hepatopulmonary syndrome will get the study placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).